Skip to main content
. 2022 Feb 4;29(2):881–891. doi: 10.3390/curroncol29020075

Figure 3.

Figure 3

The pooled analysis of the efficacy of dendritic cell vaccination on mid-term survival (A: 6-month PFS, B: 6-month OS, C: 12-month OS, D: 24-month OS).